Preclinical development of virus‐like particle (VLP)‐based immunotherapy against house dust mite allergy
Fuente:
Wiley Open Access
Enregistré dans:
| Auteurs principaux: | Piyachat Patniboon, Chanatip Thanasarnthungcharoen, Supapich Chanasit, Laurence Fievez, Theerayuth Kaewamatawong, Fabrice Bureau, Alain Jacquet |
|---|---|
| Format: | Artículo Open Access |
| Publié: |
Wiley
2024
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Immunotherapeutic effects of specific and nonspecific mRNA‐lipid nanoparticles in a mouse model of HDM‐induced airway inflammation
par: Chanatip Thanasarnthungcharoen, et autres
Publié: (2024)
par: Chanatip Thanasarnthungcharoen, et autres
Publié: (2024)
Immune signatures predict response to house dust mite subcutaneous immunotherapy in patients with allergic rhinitis
par: Nan Wang, et autres
Publié: (2024)
par: Nan Wang, et autres
Publié: (2024)
One‐strength dose escalation of house dust mite depot product for subcutaneous immunotherapy is safe and tolerable
par: M. Jutel, et autres
Publié: (2024)
par: M. Jutel, et autres
Publié: (2024)
Systemic reactions to house dust mite subcutaneous immunotherapy in patients with allergic rhinitis and/or asthma: A real‐life, multi‐center study
par: Qingxiu Xu, et autres
Publié: (2024)
par: Qingxiu Xu, et autres
Publié: (2024)
Correction to “Increase in the prevalence of follicular regulatory T cells correlates with clinical efficacy of sublingual immunotherapy with house dust mites”
Publié: (2024)
Publié: (2024)
STING ‐dependent induction of neutrophilic asthma exacerbation in response to house dust mite
par: Yasmine Messaoud‐Nacer, et autres
Publié: (2024)
par: Yasmine Messaoud‐Nacer, et autres
Publié: (2024)
Efficacy and safety of sublingual immunotherapy using house dust mite tablet for 1–4 years old children with perennial allergic rhinitis
par: Koki Sasamoto, et autres
Publié: (2024)
par: Koki Sasamoto, et autres
Publié: (2024)
Editorial comment on “Efficacy and safety of sublingual immunotherapy using house dust mite tablet for 1–4 years old children with perennial allergic rhinitis”
par: Umit Murat Sahiner, et autres
Publié: (2024)
par: Umit Murat Sahiner, et autres
Publié: (2024)
Single‐cell profiling highlight pathogenic myeloid features in house dust mite‐induced murine model of airway inflammation
par: Jiachen Liu, et autres
Publié: (2024)
par: Jiachen Liu, et autres
Publié: (2024)
Evaluation of oral immunotherapy in hazelnut allergy: Pediatric experience in Toulouse
par: N. Casanovas, et autres
Publié: (2024)
par: N. Casanovas, et autres
Publié: (2024)
Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapy
par: Matthew F. Wipperman, et autres
Publié: (2024)
par: Matthew F. Wipperman, et autres
Publié: (2024)
Utility of silver birch and house dust mite extracts derived from licensed sublingual tablets for nasal allergen challenge
par: Bianca Olivieri, et autres
Publié: (2024)
par: Bianca Olivieri, et autres
Publié: (2024)
Sensitization profiles to house dust mite Dermatophagoides pteronyssinus molecular allergens in the Lithuanian population: Understanding allergic sensitization patterns
par: Gabija Biliute, et autres
Publié: (2024)
par: Gabija Biliute, et autres
Publié: (2024)
Transcriptomic changes associated with oral immunotherapy for food allergy
par: Sarah E. Ashley, et autres
Publié: (2024)
par: Sarah E. Ashley, et autres
Publié: (2024)
Epicutaneous immunotherapy for food allergy: A systematic review and meta‐analysis
par: Péter Csonka, et autres
Publié: (2025)
par: Péter Csonka, et autres
Publié: (2025)
Allergen immunotherapy adverse events in adults with respiratory allergies‐data from ADER: An EAACI task force report
par: Julijana Asllani, et autres
Publié: (2024)
par: Julijana Asllani, et autres
Publié: (2024)
How to hit the allergy target: A critical appraisal of intralymphatic immunotherapy with practical recommendations on ultrasound‐guided injections
par: Stephan Flory, et autres
Publié: (2024)
par: Stephan Flory, et autres
Publié: (2024)
Low‐dose oral immunotherapy with Lacticaseibacillus rhamnosus GG for severe peanut allergy
par: Noriyuki Yanagida, et autres
Publié: (2025)
par: Noriyuki Yanagida, et autres
Publié: (2025)
A recent patent in allergy & immunology: Biomarkers on allergen‐specific memory B cells to predict allergen immunotherapy outcome
par: Menno C. van Zelm, et autres
Publié: (2024)
par: Menno C. van Zelm, et autres
Publié: (2024)
Allergen‐specific B cell responses in oral immunotherapy‐induced desensitization, remission, and natural outgrowth in cow's milk allergy
par: Pattraporn Satitsuksanoa, et autres
Publié: (2024)
par: Pattraporn Satitsuksanoa, et autres
Publié: (2024)
Long‐term comparison of high‐ and low‐dose oral immunotherapy in children with anaphylactic cow's milk allergy
par: Yu Ito, et autres
Publié: (2025)
par: Yu Ito, et autres
Publié: (2025)
House dust mite SCIT reduces asthma risk and significantly improves long‐term rhinitis and asthma control—A RWE study
par: Marek Jutel, et autres
Publié: (2024)
par: Marek Jutel, et autres
Publié: (2024)
Immunomodulatory metabolites in I g E ‐mediated food allergy and oral immunotherapy outcomes based on metabolomic profiling
par: Yamini V. Virkud, et autres
Publié: (2024)
par: Yamini V. Virkud, et autres
Publié: (2024)
Effect of venom immunotherapy and sting challenge on health‐related quality of life measured by venom‐allergy quality of life questionnaire (VQLQ) in Jack jumper ant allergic patients
par: Kymble Spriggs, et autres
Publié: (2024)
par: Kymble Spriggs, et autres
Publié: (2024)
Succinate induces a Th2 environment in the small intestine but does not exacerbate food allergy
par: Jian Tan, et autres
Publié: (2024)
par: Jian Tan, et autres
Publié: (2024)
Editorial comment on “Immunomodulatory metabolites in IgE‐mediated food allergy and oral immunotherapy outcomes based on metabolomic profiling”
par: Martha Jimenez, et autres
Publié: (2025)
par: Martha Jimenez, et autres
Publié: (2025)
The use of omalizumab in food allergy
par: Shifaa Alkotob, et autres
Publié: (2024)
par: Shifaa Alkotob, et autres
Publié: (2024)
Legends of allergy and immunology: Otto Scheiner
par: Heimo Breiteneder, et autres
Publié: (2024)
par: Heimo Breiteneder, et autres
Publié: (2024)
Legends of allergy and immunology: Kenji Izuhara
par: Satoshi Nunomura, et autres
Publié: (2024)
par: Satoshi Nunomura, et autres
Publié: (2024)
Meta‐analysis in allergy—Statistical recommendations
par: Michal Ordak, et autres
Publié: (2024)
par: Michal Ordak, et autres
Publié: (2024)
Legends of allergy and immunology: Hirohisa Saito
par: Hideaki Morita, et autres
Publié: (2024)
par: Hideaki Morita, et autres
Publié: (2024)
Biomarkers of peanut allergy in children over time
par: Ru‐Xin Foong, et autres
Publié: (2024)
par: Ru‐Xin Foong, et autres
Publié: (2024)
A randomized, double‐blind placebo‐controlled study on the efficacy of Omalizumab on food allergy threshold in children with severe food allergy
par: Charlotte G. Mortz, et autres
Publié: (2024)
par: Charlotte G. Mortz, et autres
Publié: (2024)
An algorithm for the diagnosis of beta‐lactam allergy, 2024 update
par: Inmaculada Doña, et autres
Publié: (2024)
par: Inmaculada Doña, et autres
Publié: (2024)
The skin microbiome in pediatric atopic dermatitis and food allergy
par: Elizabeth Huiwen Tham, et autres
Publié: (2024)
par: Elizabeth Huiwen Tham, et autres
Publié: (2024)
Algorithms in allergy: Diagnosis and management of atopic dermatitis in adulthood
par: M. Grace Hren, et autres
Publié: (2024)
par: M. Grace Hren, et autres
Publié: (2024)
Algorithms in allergy: Management of allergic reactions to COVID‐19 vaccines
par: Mary Johnson, et autres
Publié: (2024)
par: Mary Johnson, et autres
Publié: (2024)
From bite to brain: Neuro‐immune interactions in food allergy
par: Vikki Houghton, et autres
Publié: (2024)
par: Vikki Houghton, et autres
Publié: (2024)
An algorithm for the diagnosis and treatment of Hymenoptera venom allergy, 2024 update
par: Gunter J. Sturm, et autres
Publié: (2024)
par: Gunter J. Sturm, et autres
Publié: (2024)
Preventive allergen immunotherapy with inhalant allergens in children
par: Varsha Dwivedi, et autres
Publié: (2024)
par: Varsha Dwivedi, et autres
Publié: (2024)
Documents similaires
-
Immunotherapeutic effects of specific and nonspecific mRNA‐lipid nanoparticles in a mouse model of HDM‐induced airway inflammation
par: Chanatip Thanasarnthungcharoen, et autres
Publié: (2024) -
Immune signatures predict response to house dust mite subcutaneous immunotherapy in patients with allergic rhinitis
par: Nan Wang, et autres
Publié: (2024) -
One‐strength dose escalation of house dust mite depot product for subcutaneous immunotherapy is safe and tolerable
par: M. Jutel, et autres
Publié: (2024) -
Systemic reactions to house dust mite subcutaneous immunotherapy in patients with allergic rhinitis and/or asthma: A real‐life, multi‐center study
par: Qingxiu Xu, et autres
Publié: (2024) -
Correction to “Increase in the prevalence of follicular regulatory T cells correlates with clinical efficacy of sublingual immunotherapy with house dust mites”
Publié: (2024)